发文地区与机构
近年国家 / 地区发文量统计
| 国家 / 地区 | 发文量 |
|---|---|
| CHINA MAINLAND | 107 |
| Italy | 41 |
| South Korea | 10 |
| USA | 7 |
| GERMANY (FED REP GER) | 5 |
| India | 4 |
| Iran | 4 |
| Turkey | 4 |
| England | 3 |
| Netherlands | 3 |
近年机构发文量统计
| 机构 | 发文量 |
|---|---|
| EULJI UNIVERSITY | 6 |
| CAPITAL MEDICAL UNIVERSITY | 5 |
| IRCCS ISTITUTO ONCOLOGICO VENETO (IOV) | 5 |
| NANJING MEDICAL UNIVERSITY | 5 |
| PEKING UNIVERSITY | 5 |
| SICHUAN UNIVERSITY | 5 |
| UNIVERSITY OF PADUA | 5 |
| HUAZHONG UNIVERSITY OF SCIENCE & TECHNO... | 4 |
| NANCHANG UNIVERSITY | 4 |
| SHANGHAI JIAO TONG UNIVERSITY | 4 |
文章引用情况
1
Circulating tumor DNA as prognostic markers for late stage NSCLC with bone metastasis2
Prognostic value of the Glasgow prognostic score in lung cancer: evidence from 10 studies3
Deciphering the potential value of 5-fluorouracil metabolic enzymes in predicting prognosis and treatment response of colorectal cancer patients4
BTG1 low expression in pancreatic ductal adenocarcinoma is associated with a poorer prognosis5
The role of selected chemokines and their specific receptors in pancreatic cancer6
Diagnostic value of CD56 immunohistochemistry in thyroid lesions7
Procalcitonin as a postoperative marker in the follow-up of patients affected by medullary thyroid carcinoma8
Changes of breast cancer staging when AJCC prognostic staging manual is used: a retrospective analysis of a Chinese cohort9
Unfavorable clinical implications of peripheral blood CD44+and CD54+lymphocytes in patients with lung cancer undergoing chemotherapy10
miR-142-3p as a novel biomarker for predicting poor prognosis in renal cell carcinoma patients after surgery